我的购物车

CD30 [Biotinylated] : CD30L Inhibitor Screening ELISA Kit

用户评价
货号-规格
价格
Qty.
合计0件 产品金额0
0
加入购物车

产品详情

  • 组分(Materials Provided)

    ID
    Components
    Size
    EP135-C01
    High-bind Plate
    1 plate
    EP135-C02
    Human CD30L
    15 μg
    EP135-C03
    Biotinylated Human CD30
    10 μg
    EP135-C04
    Anti-CD30 Neutralizing Antibody
    20 μg
    EP135-C05
    Streptavidin-HRP
    10 μg
    EP135-C06
    Coating Buffer
    12 mL
    EP135-C07
    10xWashing Buffer
    50 mL
    EP135-C08
    Blocking Buffer
    50 mL
    EP135-C09
    Substrate Solution
    12 mL
    EP135-C10
    Stop Solution
    7 mL

  • 产品概述(Product Overview)

    CD30 [Biotinylated] : CD30L Inhibitor Screening ELISA Kit is based on a competition-ELISA method, is used to screening for inhibitors of human CD30 binding to human CD30L. The kit is designed to provide a reliable solution for the screening of antibodies and small molecule inhibitors in the early stages, as well as QC release, to help researchers quickly screen and validate drugs, effectively improving research and development efficiency. It can also be used as a universal detection tool to identify the ability of human CD30 binding to human CD30L.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • 存储(Storage)

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

数据展示

  • 典型数据-Typical Data

    Please refer to DS document for the assay protocol.

     CD30 TYPICAL DATA

    INHIBITION OF CD30[Biotinylated]: CD30L BINDING BY ANTI-CD30 NEUTRALIZING ANTIBODY
    Serial dilutions of Anti-CD30 Neutralizing antibody (Catalog # EP135-C04) (1:1 serial dilution, from 5 μg/mL to 0.019μg/mL) was added into Biotinylated CD30: CD30L binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    Tumor necrosis factor receptor superfamily member 8

  • 中文全称:

    肿瘤坏死因子受体超家族成员8

  • 种类:

  • 上市药物数量:

    1 详情

  • 临床药物数量:

    23 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
  • 产品基础信息
  • 产品详情
  • 数据展示
  • 用户评价